{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:27:40Z","timestamp":1786994860010,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.neurobiolaging.2018.09.001","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T19:20:03Z","timestamp":1536434403000},"page":"21-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Blood acetylcholinesterase level is a potential biomarker for the early detection of cerebral amyloid deposition in cognitively normal individuals"],"prefix":"10.1016","volume":"73","author":[{"given":"Sun-Ho","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Soo","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahyun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inhee","family":"Mook-Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib1","first-page":"48","article-title":"Plasma acetylcholinesterase activity correlates with intracerebral beta-amyloid load","volume":"10","author":"Alkalay","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib2","series-title":"Electronic DSM-IV-TR Plus, 1.0","first-page":"1","year":"2000"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(85)90182-0","article-title":"Blood acetyl- and butyrylcholinesterases in senile dementia of Alzheimer type","volume":"70","author":"Atack","year":"1985","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4306\/pi.2017.14.6.851","article-title":"Korean brain aging study for the early diagnosis and prediction of Alzheimer's disease: Methodology and Baseline sample characteristics","volume":"14","author":"Byun","year":"2017","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib7","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.neurobiolaging.2014.01.013","article-title":"Association of homocysteine with hippocampal volume independent of cerebral amyloid and vascular burden","volume":"35","author":"Choe","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1423-0410.2007.00970.x","article-title":"Functions of red cell surface proteins","volume":"93","author":"Daniels","year":"2007","journal-title":"Vox Sang"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3233\/CH-168023","article-title":"An ex\u00a0vivo study of nitric oxide efflux from human erythrocytes in both genders","volume":"64","author":"Duarte","year":"2016","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jalz.2016.12.003","article-title":"Preclinical Alzheimer's disease: a systematic review of the cohorts underlying the concept","volume":"13","author":"Epelbaum","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer's disease: a review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib14","first-page":"232","article-title":"Acetylcholinesterase provides new insights into red blood cell ageing in\u00a0vivo and in\u00a0vitro","volume":"15","author":"Freitas Leal","year":"2017","journal-title":"Blood Transfus."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib15","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0024-3205(03)00063-8","article-title":"Introduction: the non-neuronal cholinergic system in humans","volume":"72","author":"Grando","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2015.12.004","article-title":"Amyloid beta-interacting partners in Alzheimer's disease: from accomplices to possible therapeutic targets","volume":"137","author":"Han","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1471-4159.2003.01855.x","article-title":"Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation","volume":"86","author":"Hu","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib20","first-page":"253","article-title":"Acetylcholinesterase in the erythrocyte membrane","volume":"16","author":"Igisu","year":"1994","journal-title":"J.\u00a0UOEH"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(94)90044-2","article-title":"Blood markers in Alzheimer disease: subnormal acetylcholinesterase and butyrylcholinesterase in lymphocytes and erythrocytes","volume":"122","author":"Inestrosa","year":"1994","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"Pt 3","key":"10.1016\/j.neurobiolaging.2018.09.001_bib22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","article-title":"11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment","volume":"131","author":"Jack","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib23","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib24","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3233\/JAD-160025","article-title":"PiB-pet imaging-based Serum Proteome Profiles predict mild cognitive impairment and Alzheimer's disease","volume":"53","author":"Kang","year":"2016","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib25","first-page":"427","article-title":"Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease","volume":"29","author":"Kar","year":"2004","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.lfs.2003.09.037","article-title":"The lymphocytic cholinergic system and its contribution to the regulation of immune activity","volume":"74","author":"Kawashima","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0197-4580(84)90002-2","article-title":"CSF acetylcholinesterase in dementia and in sequential samples of lumbar CSF","volume":"5","author":"Lal","year":"1984","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1017\/S1355617704101094","article-title":"A\u00a0normative study of the CERAD neuropsychological assessment battery in the Korean elderly","volume":"10","author":"Lee","year":"2004","journal-title":"J.\u00a0Int. Neuropsychol. Soc."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib30","doi-asserted-by":"crossref","first-page":"P47","DOI":"10.1093\/geronb\/57.1.P47","article-title":"Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's disease assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries","volume":"57","author":"Lee","year":"2002","journal-title":"J.\u00a0Gerontol. B Psychol. Sci. Soc. Sci."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A\u00a0specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib32","doi-asserted-by":"crossref","first-page":"321213","DOI":"10.1155\/2013\/321213","article-title":"Acetylcholinesterase as a biomarker in environmental and occupational medicine: new insights and future perspectives","volume":"2013","author":"Lionetto","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/187152710791012071","article-title":"Microglia and inflammation in Alzheimer's disease","volume":"9","author":"Mandrekar-Colucci","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0006-3223(85)90095-2","article-title":"Cholinesterase activity in plasma, erythrocytes, and cerebrospinal fluid of patients with dementia of the Alzheimer type","volume":"20","author":"Marquis","year":"1985","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib36","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrneurol.2009.217","article-title":"The use of PET in Alzheimer disease","volume":"6","author":"Nordberg","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib38","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.2015.4669","article-title":"Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis","volume":"313","author":"Ossenkoppele","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fnagi.2017.00362","article-title":"Low Serum Phosphorus correlates with cerebral Abeta deposition in cognitively impaired subjects: results from the KBASE study","volume":"9","author":"Park","year":"2017","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13195-017-0248-8","article-title":"Chemically treated plasma Abeta is a potential blood-based biomarker for screening cerebral amyloid deposition","volume":"9","author":"Park","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0022-510X(77)90073-9","article-title":"Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue","volume":"34","author":"Perry","year":"1977","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(77)91780-9","article-title":"Necropsy evidence of central cholinergic deficits in senile dementia","volume":"1","author":"Perry","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib43","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/geronb\/gbs077","article-title":"Coordinated analysis of age, sex, and education effects on change in MMSE scores","volume":"68","author":"Piccinin","year":"2013","journal-title":"J.\u00a0Gerontol. B Psychol. Sci. Soc. Sci."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib44","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.npp.1301485","article-title":"Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens","volume":"33","author":"Preda","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cbi.2005.10.034","article-title":"Peripheral cholinergic disturbances in Alzheimer's disease","volume":"157-158","author":"Rakonczay","year":"2005","journal-title":"Chem. Biol. Interact"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib46","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0197-4580(02)00230-0","article-title":"Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex","volume":"24","author":"Rees","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib47","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp.74.1.113","article-title":"Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease","volume":"74","author":"Rinne","year":"2003","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pneurobio.2009.01.001","article-title":"Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors","volume":"87","author":"Salminen","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib50","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1046\/j.1471-4159.1998.71020723.x","article-title":"Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease","volume":"71","author":"Sberna","year":"1998","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF01677425","article-title":"Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease","volume":"75","author":"Sirvio","year":"1989","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib52","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ageing\/afl027","article-title":"Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!","volume":"35","author":"Tabet","year":"2006","journal-title":"Age Ageing"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib53","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF00307630","article-title":"Senile plaques: staining for acetylcholinesterase and A4 protein: a comparative study in the hippocampus and entorhinal cortex","volume":"80","author":"Ulrich","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM198902093200606","article-title":"Tissue destruction by neutrophils","volume":"320","author":"Weiss","year":"1989","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib55","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/bjp.2008.185","article-title":"Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans","volume":"154","author":"Wessler","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib56","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/ageing\/afi189","article-title":"Enzymes of drug metabolism during delirium","volume":"34","author":"White","year":"2005","journal-title":"Age Ageing"},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/nbdi.1997.0147","article-title":"Biology of A beta amyloid in Alzheimer's disease","volume":"4","author":"Wisniewski","year":"1997","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2018.09.001_bib58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jama.2010.1995","article-title":"Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline","volume":"305","author":"Yaffe","year":"2011","journal-title":"JAMA"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018303245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018303245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T23:43:40Z","timestamp":1720568620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458018303245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":58,"alternative-id":["S0197458018303245"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.09.001","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood acetylcholinesterase level is a potential biomarker for the early detection of cerebral amyloid deposition in cognitively normal individuals","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}